Paul Fennessy

Paul Fennessy (BSc(Hons), PhD) has more than 35 years of experience in medical research, in national HTA and in health policy, including state health department representative on/chairing various national committees regarding horizon scanning, genomics and health technology assessment, reimbursement and commissioning. Paul was responsible for oversighting the commissioning of cell and gene therapies in selected public hospitals and jointly developed the National Framework for assessing, funding and implementing highly specialised therapies and highly specialised services. He also proposed the development of a national policy framework for clinical genomics on the basis that genomic sequencing would be a disruptive technology that would significantly impact patient access, budgets and service delivery, which resulted in the development and implementation of the National Health Genomics Policy Framework. Paul now consults, offering advice informing policy, strategic, investment and commissioning/implementation decisions, with a focus on expediting assessment, reimbursement and delivery of cell and gene therapies to patients.